Key Highlights
- Net loss attributable to shareholders was USD 30.4 million, or USD 0.22 per share.
- The USD 0.22 loss compares with an estimated USD 0.15 loss.
- Cash and cash equivalents were USD 201.7 million at September 30, 2026.
- Acquisitions added USD 0.8 million and USD 0.9 million of revenue.
Loss Widens on the Quarter
ASP Isotopes Inc. (NASDAQ:ASPI) reported a third-quarter net loss attributable to shareholders of USD 30,371 thousand versus USD 12,617 thousand a year earlier. The loss per share from continuing operations was USD 0.22 versus USD 0.15, compared with an estimated loss of USD 0.15 per share. Net loss attributable to noncontrolling interests was USD 497 thousand.
For the nine months, net loss attributable to shareholders was USD 70,833 thousand versus USD 96,125 thousand, with continuing operations at USD 0.71 per share versus USD 1.27 and discontinued operations contributing USD 0.15 per share following a separation transaction.
Revenue Sources
The filing attributes Revenue growth to three items: USD 0.8 million related to the January 2026 Acquisition of NuMed, USD 0.9 million related to the October 2025 acquisition of ECNP, and a USD 1.3 million increase from higher sales across its nuclear medicine pipeline.
The company calls itself an "advanced materials company dedicated to the development of a differentiated isotope enrichment platform" serving nuclear medicine, next-generation semiconductors and nuclear energy, using proprietary technologies including aerodynamic separation.
The loss per share compares with an estimated loss of USD 0.15 in the data set, and the revenue estimate was USD 5.68 million.
Cash and Separation Effects
Cash and cash equivalents were USD 201.7 million at September 30, 2026. Nine-month cash used in operations was explained by the net loss from continuing operations adjusted for a USD 19.3 million gain on deconsolidation, a USD 11.3 million gain on extinguishment of convertible notes, USD 18.6 million of stock-based compensation and other non-cash items. The separation reduced stockholders' Equity by USD 66.1 million from discontinued operations.
The filing reports that the nine-month net loss from continuing operations was adjusted for these non-cash items in reconciling to operating cash flow, which keeps the cash balance as the main Liquidity figure.
The statement of operations also shows net loss attributable to noncontrolling interests of USD 497 thousand for the quarter versus USD 277 thousand, and USD 1,149 thousand for the nine months versus USD 387 thousand. Nine-month loss per share from continuing operations improved to USD 0.71 from USD 1.27, partly because the prior-year nine-month result was larger in absolute terms at USD 96,125 thousand against USD 70,833 thousand this year.
Metrics to Track
Reference points include revenue contribution from the acquired businesses, stock-based compensation, progress on enrichment capacity and the use of the cash balance.
The quarterly loss per share of USD 0.22 and the USD 201.7 million cash balance are the two figures to read together in the next report.






Please wait processing your request...